Genomma LabPresident Brazil
Dec. 2016 - Mar. 2019São Paulo Area, BrazilA $1B Mexican cosmetics/personal care and pharmaceutical public company with presence in Latin America and the US. Company products include shampoo, anti-aging cream, moisturizing cream, and OTC product brands such as Tío Nacho, Asepxia, Cicatricure, Medicasp, Tukol, Next, Lomecan, and Unesia. The company is the #1 TV advertiser in most of the countries where it operates. www.genommalab.com Oversee all aspects of business development initiatives, marketing and operations for Brazil including providing leadership for a staff of 60 and overseeing a business unit generating $58M in annual revenues. Tasked with growing the business including EBITDA and cash flow by re-designing the marketing strategy, promoting local manufacturing, and achieving operational excellence. After three years of decline, Genomma Brazil grew again in 2018 +11.9% versus 2017, while the market grew 4.4% (IMS). EBITDA grew +691% vs 2017 at 12% to Sales. In parallel, I improved Corporate Climate. Opened Lojas Americanas, the top Personal Care Retailer in Brazil (+1,300 stores), with the majority of Genomma’s portfolio. Designed the M&A strategy to support the Brazilian business growth. 2017 results included a 22% SG&A reduction, 433% EBITDA increase, 28% reduction in headcount, reduced days of inventories (DOIs) from 169 days to 61 days, and reduction of the cash conversion cycle (CCC) from 174 days to 59 days. Conducted an extensive revamp of staff and the leadership team including the hire of high performing team members. Cultivated a partnership with one of the largest pharmaceutical companies in Brazil to manufacture OTC products. Championed the launch of Cicatricure Serum in 10/2017 acquiring 14% market share and increasing the value of the category by 22% in only three months (source: IMS). Developed alternate sales channels such as e-commerce and “perfumeries”. Implemented a POS Display reaching 14,000 stores in 4 months